nodes	percent_of_prediction	percent_of_DWPC	metapath
Gonadorelin—Developmental delay—Nevirapine—acquired immunodeficiency syndrome	0.0292	0.036	CcSEcCtD
Gonadorelin—Congenital anomaly—Nevirapine—acquired immunodeficiency syndrome	0.0292	0.036	CcSEcCtD
Gonadorelin—Congenital anomaly—Zidovudine—acquired immunodeficiency syndrome	0.0245	0.0302	CcSEcCtD
Gonadorelin—Developmental delay—Zidovudine—acquired immunodeficiency syndrome	0.0245	0.0302	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—ACKR1—acquired immunodeficiency syndrome	0.0206	0.109	CbGpPWpGaD
Gonadorelin—GNRHR—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	0.0174	0.0923	CbGpPWpGaD
Gonadorelin—Pelvic pain—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0147	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—CCR2—acquired immunodeficiency syndrome	0.0115	0.0608	CbGpPWpGaD
Gonadorelin—Pelvic pain—Saquinavir—acquired immunodeficiency syndrome	0.0114	0.0141	CcSEcCtD
Gonadorelin—Haematoma—Saquinavir—acquired immunodeficiency syndrome	0.0111	0.0137	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—CXCR4—acquired immunodeficiency syndrome	0.0108	0.0572	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	0.0107	0.0567	CbGpPWpGaD
Gonadorelin—Contusion—Delavirdine—acquired immunodeficiency syndrome	0.00896	0.0111	CcSEcCtD
Gonadorelin—Breast pain—Ritonavir—acquired immunodeficiency syndrome	0.00829	0.0102	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00816	0.0432	CbGpPWpGaD
Gonadorelin—Abdominal discomfort—Amprenavir—acquired immunodeficiency syndrome	0.00813	0.01	CcSEcCtD
Gonadorelin—GNRHR—Peptide GPCRs—CCR5—acquired immunodeficiency syndrome	0.00741	0.0392	CbGpPWpGaD
Gonadorelin—Swelling—Indinavir—acquired immunodeficiency syndrome	0.00712	0.00878	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00649	0.0343	CbGpPWpGaD
Gonadorelin—Swelling—Delavirdine—acquired immunodeficiency syndrome	0.00644	0.00793	CcSEcCtD
Gonadorelin—Abdominal discomfort—Abacavir—acquired immunodeficiency syndrome	0.00634	0.00782	CcSEcCtD
Gonadorelin—GNRHR—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00628	0.0332	CbGpPWpGaD
Gonadorelin—Breast disorder—Zidovudine—acquired immunodeficiency syndrome	0.0061	0.00752	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00587	0.0311	CbGpPWpGaD
Gonadorelin—Flatulence—Amprenavir—acquired immunodeficiency syndrome	0.00583	0.00718	CcSEcCtD
Gonadorelin—Breast disorder—Efavirenz—acquired immunodeficiency syndrome	0.00536	0.00661	CcSEcCtD
Gonadorelin—Flatulence—Didanosine—acquired immunodeficiency syndrome	0.00531	0.00655	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Indinavir—acquired immunodeficiency syndrome	0.00504	0.00622	CcSEcCtD
Gonadorelin—Immune system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00503	0.0062	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00494	0.0262	CbGpPWpGaD
Gonadorelin—Angiopathy—Nelfinavir—acquired immunodeficiency syndrome	0.00489	0.00603	CcSEcCtD
Gonadorelin—Immune system disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00487	0.006	CcSEcCtD
Gonadorelin—Erythema—Nevirapine—acquired immunodeficiency syndrome	0.00485	0.00597	CcSEcCtD
Gonadorelin—Immune system disorder—Abacavir—acquired immunodeficiency syndrome	0.00478	0.0059	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Efavirenz—acquired immunodeficiency syndrome	0.00477	0.00588	CcSEcCtD
Gonadorelin—Breast disorder—Ritonavir—acquired immunodeficiency syndrome	0.00474	0.00585	CcSEcCtD
Gonadorelin—Nervous system disorder—Amprenavir—acquired immunodeficiency syndrome	0.00473	0.00583	CcSEcCtD
Gonadorelin—Erythema—Nelfinavir—acquired immunodeficiency syndrome	0.00469	0.00579	CcSEcCtD
Gonadorelin—Flatulence—Nelfinavir—acquired immunodeficiency syndrome	0.00462	0.0057	CcSEcCtD
Gonadorelin—Flatulence—Stavudine—acquired immunodeficiency syndrome	0.00461	0.00568	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Delavirdine—acquired immunodeficiency syndrome	0.00456	0.00562	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.00447	0.0237	CbGpPWpGaD
Gonadorelin—Anaphylactic shock—Didanosine—acquired immunodeficiency syndrome	0.0044	0.00542	CcSEcCtD
Gonadorelin—Abdominal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.00419	0.00516	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00419	0.0222	CbGpPWpGaD
Gonadorelin—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.00417	0.00514	CcSEcCtD
Gonadorelin—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.00416	0.00513	CcSEcCtD
Gonadorelin—Erythema—Zidovudine—acquired immunodeficiency syndrome	0.00407	0.00501	CcSEcCtD
Gonadorelin—Upper respiratory tract infection—Saquinavir—acquired immunodeficiency syndrome	0.00406	0.005	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00401	0.0212	CbGpPWpGaD
Gonadorelin—Flatulence—Zidovudine—acquired immunodeficiency syndrome	0.00401	0.00494	CcSEcCtD
Gonadorelin—Abdominal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.00399	0.00492	CcSEcCtD
Gonadorelin—Anaphylactic shock—Nevirapine—acquired immunodeficiency syndrome	0.00395	0.00488	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Amprenavir—acquired immunodeficiency syndrome	0.00395	0.00486	CcSEcCtD
Gonadorelin—Immune system disorder—Indinavir—acquired immunodeficiency syndrome	0.00392	0.00484	CcSEcCtD
Gonadorelin—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.00388	0.00478	CcSEcCtD
Gonadorelin—Abdominal pain—Amprenavir—acquired immunodeficiency syndrome	0.00381	0.0047	CcSEcCtD
Gonadorelin—Anaphylactic shock—Abacavir—acquired immunodeficiency syndrome	0.00376	0.00464	CcSEcCtD
Gonadorelin—Pain—Didanosine—acquired immunodeficiency syndrome	0.00376	0.00464	CcSEcCtD
Gonadorelin—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.00374	0.00462	CcSEcCtD
Gonadorelin—Flatulence—Indinavir—acquired immunodeficiency syndrome	0.00373	0.00459	CcSEcCtD
Gonadorelin—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.00372	0.00459	CcSEcCtD
Gonadorelin—Immune system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00371	0.00457	CcSEcCtD
Gonadorelin—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00369	0.00455	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.00363	0.0192	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Didanosine—acquired immunodeficiency syndrome	0.0036	0.00443	CcSEcCtD
Gonadorelin—Erythema—Efavirenz—acquired immunodeficiency syndrome	0.00357	0.00441	CcSEcCtD
Gonadorelin—Flatulence—Efavirenz—acquired immunodeficiency syndrome	0.00352	0.00434	CcSEcCtD
Gonadorelin—Abdominal pain—Didanosine—acquired immunodeficiency syndrome	0.00348	0.00429	CcSEcCtD
Gonadorelin—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.00346	0.00427	CcSEcCtD
Gonadorelin—Erythema—Delavirdine—acquired immunodeficiency syndrome	0.00342	0.00422	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00341	0.00421	CcSEcCtD
Gonadorelin—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00341	0.00421	CcSEcCtD
Gonadorelin—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.00341	0.0042	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.00341	0.018	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.00341	0.018	CbGpPWpGaD
Gonadorelin—Pain—Nevirapine—acquired immunodeficiency syndrome	0.00338	0.00417	CcSEcCtD
Gonadorelin—Flatulence—Delavirdine—acquired immunodeficiency syndrome	0.00337	0.00415	CcSEcCtD
Gonadorelin—Anaphylactic shock—Zidovudine—acquired immunodeficiency syndrome	0.00332	0.00409	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.00331	0.00408	CcSEcCtD
Gonadorelin—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.0033	0.00407	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.0033	0.00406	CcSEcCtD
Gonadorelin—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.0033	0.00406	CcSEcCtD
Gonadorelin—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.00329	0.00406	CcSEcCtD
Gonadorelin—Immune system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00328	0.00404	CcSEcCtD
Gonadorelin—Pain—Nelfinavir—acquired immunodeficiency syndrome	0.00328	0.00404	CcSEcCtD
Gonadorelin—Constipation—Stavudine—acquired immunodeficiency syndrome	0.00327	0.00403	CcSEcCtD
Gonadorelin—Pain—Stavudine—acquired immunodeficiency syndrome	0.00327	0.00403	CcSEcCtD
Gonadorelin—Shock—Zidovudine—acquired immunodeficiency syndrome	0.00327	0.00403	CcSEcCtD
Gonadorelin—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.00325	0.00401	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.00325	0.004	CcSEcCtD
Gonadorelin—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.00324	0.004	CcSEcCtD
Gonadorelin—Hypersensitivity—Didanosine—acquired immunodeficiency syndrome	0.00324	0.004	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Nevirapine—acquired immunodeficiency syndrome	0.00323	0.00399	CcSEcCtD
Gonadorelin—Pain—Abacavir—acquired immunodeficiency syndrome	0.00322	0.00397	CcSEcCtD
Gonadorelin—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.00317	0.00391	CcSEcCtD
Gonadorelin—Immune system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00316	0.00389	CcSEcCtD
Gonadorelin—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.00316	0.00389	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00313	0.00386	CcSEcCtD
Gonadorelin—Abdominal pain—Nevirapine—acquired immunodeficiency syndrome	0.00313	0.00385	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Stavudine—acquired immunodeficiency syndrome	0.00312	0.00385	CcSEcCtD
Gonadorelin—Flatulence—Ritonavir—acquired immunodeficiency syndrome	0.00312	0.00384	CcSEcCtD
Gonadorelin—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.00311	0.00384	CcSEcCtD
Gonadorelin—Anaphylactic shock—Indinavir—acquired immunodeficiency syndrome	0.00309	0.00381	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Abacavir—acquired immunodeficiency syndrome	0.00308	0.00379	CcSEcCtD
Gonadorelin—Vomiting—Amprenavir—acquired immunodeficiency syndrome	0.00307	0.00378	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00305	0.0162	CbGpPWpGaD
Gonadorelin—Erythema—Saquinavir—acquired immunodeficiency syndrome	0.00304	0.00375	CcSEcCtD
Gonadorelin—Shock—Indinavir—acquired immunodeficiency syndrome	0.00304	0.00374	CcSEcCtD
Gonadorelin—Abdominal pain—Nelfinavir—acquired immunodeficiency syndrome	0.00303	0.00373	CcSEcCtD
Gonadorelin—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.00303	0.00373	CcSEcCtD
Gonadorelin—Headache—Amprenavir—acquired immunodeficiency syndrome	0.00302	0.00373	CcSEcCtD
Gonadorelin—Abdominal pain—Stavudine—acquired immunodeficiency syndrome	0.00302	0.00372	CcSEcCtD
Gonadorelin—Immune system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00301	0.00371	CcSEcCtD
Gonadorelin—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.00301	0.00371	CcSEcCtD
Gonadorelin—Flatulence—Saquinavir—acquired immunodeficiency syndrome	0.003	0.0037	CcSEcCtD
Gonadorelin—Abdominal pain—Abacavir—acquired immunodeficiency syndrome	0.00297	0.00367	CcSEcCtD
Gonadorelin—Hypersensitivity—Nevirapine—acquired immunodeficiency syndrome	0.00291	0.00359	CcSEcCtD
Gonadorelin—Erythema—Lamivudine—acquired immunodeficiency syndrome	0.0029	0.00358	CcSEcCtD
Gonadorelin—Shock—Efavirenz—acquired immunodeficiency syndrome	0.00287	0.00354	CcSEcCtD
Gonadorelin—Nausea—Amprenavir—acquired immunodeficiency syndrome	0.00287	0.00353	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.00287	0.00353	CcSEcCtD
Gonadorelin—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.00286	0.00353	CcSEcCtD
Gonadorelin—Flatulence—Lamivudine—acquired immunodeficiency syndrome	0.00286	0.00353	CcSEcCtD
Gonadorelin—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.00286	0.00353	CcSEcCtD
Gonadorelin—Pain—Zidovudine—acquired immunodeficiency syndrome	0.00284	0.0035	CcSEcCtD
Gonadorelin—Constipation—Zidovudine—acquired immunodeficiency syndrome	0.00284	0.0035	CcSEcCtD
Gonadorelin—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.00284	0.0035	CcSEcCtD
Gonadorelin—Hypersensitivity—Nelfinavir—acquired immunodeficiency syndrome	0.00282	0.00348	CcSEcCtD
Gonadorelin—Hypersensitivity—Stavudine—acquired immunodeficiency syndrome	0.00281	0.00347	CcSEcCtD
Gonadorelin—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.0028	0.00345	CcSEcCtD
Gonadorelin—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.0028	0.00345	CcSEcCtD
Gonadorelin—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.00277	0.00342	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.00276	0.0146	CbGpPWpGaD
Gonadorelin—Headache—Didanosine—acquired immunodeficiency syndrome	0.00276	0.0034	CcSEcCtD
Gonadorelin—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.00275	0.00339	CcSEcCtD
Gonadorelin—Shock—Delavirdine—acquired immunodeficiency syndrome	0.00275	0.00338	CcSEcCtD
Gonadorelin—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.00274	0.00338	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.00271	0.00335	CcSEcCtD
Gonadorelin—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.00271	0.00334	CcSEcCtD
Gonadorelin—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.00271	0.00334	CcSEcCtD
Gonadorelin—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.0027	0.00333	CcSEcCtD
Gonadorelin—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.0027	0.00333	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00266	0.00329	CcSEcCtD
Gonadorelin—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00266	0.00328	CcSEcCtD
Gonadorelin—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00266	0.00328	CcSEcCtD
Gonadorelin—Constipation—Indinavir—acquired immunodeficiency syndrome	0.00264	0.00325	CcSEcCtD
Gonadorelin—Pain—Indinavir—acquired immunodeficiency syndrome	0.00264	0.00325	CcSEcCtD
Gonadorelin—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.00262	0.00323	CcSEcCtD
Gonadorelin—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00262	0.00323	CcSEcCtD
Gonadorelin—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.00261	0.00322	CcSEcCtD
Gonadorelin—Nausea—Didanosine—acquired immunodeficiency syndrome	0.00261	0.00322	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.0026	0.0137	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.0026	0.0137	CbGpPWpGaD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.00259	0.0137	CbGpPWpGaD
Gonadorelin—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.00257	0.00317	CcSEcCtD
Gonadorelin—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00254	0.00313	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00254	0.0134	CbGpPWpGaD
Gonadorelin—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.00253	0.00312	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.00252	0.00311	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00252	0.0031	CcSEcCtD
Gonadorelin—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00251	0.0031	CcSEcCtD
Gonadorelin—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00251	0.0031	CcSEcCtD
Gonadorelin—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00307	CcSEcCtD
Gonadorelin—Pain—Efavirenz—acquired immunodeficiency syndrome	0.00249	0.00307	CcSEcCtD
Gonadorelin—Headache—Nevirapine—acquired immunodeficiency syndrome	0.00248	0.00305	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.00247	0.0131	CbGpPWpGaD
Gonadorelin—Shock—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.00301	CcSEcCtD
Gonadorelin—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.00244	0.00301	CcSEcCtD
Gonadorelin—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.00244	0.003	CcSEcCtD
Gonadorelin—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.00244	0.003	CcSEcCtD
Gonadorelin—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.00243	0.00299	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.00241	0.00297	CcSEcCtD
Gonadorelin—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.00241	0.00297	CcSEcCtD
Gonadorelin—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.0024	0.00296	CcSEcCtD
Gonadorelin—Headache—Stavudine—acquired immunodeficiency syndrome	0.00239	0.00295	CcSEcCtD
Gonadorelin—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.00239	0.00295	CcSEcCtD
Gonadorelin—Pain—Delavirdine—acquired immunodeficiency syndrome	0.00239	0.00294	CcSEcCtD
Gonadorelin—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.00239	0.00294	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.00238	0.00294	CcSEcCtD
Gonadorelin—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.00238	0.00294	CcSEcCtD
Gonadorelin—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00237	0.00292	CcSEcCtD
Gonadorelin—Headache—Abacavir—acquired immunodeficiency syndrome	0.00236	0.00291	CcSEcCtD
Gonadorelin—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.00235	0.0029	CcSEcCtD
Gonadorelin—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.00235	0.00289	CcSEcCtD
Gonadorelin—GNRHR—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00234	0.0124	CbGpPWpGaD
Gonadorelin—Shock—Lamivudine—acquired immunodeficiency syndrome	0.00233	0.00287	CcSEcCtD
Gonadorelin—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.00232	0.00286	CcSEcCtD
Gonadorelin—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00231	0.00284	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.00229	0.0121	CbGpPWpGaD
Gonadorelin—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00228	0.00281	CcSEcCtD
Gonadorelin—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00228	0.0028	CcSEcCtD
Gonadorelin—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00227	0.0028	CcSEcCtD
Gonadorelin—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00227	0.0028	CcSEcCtD
Gonadorelin—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00227	0.0028	CcSEcCtD
Gonadorelin—Nausea—Abacavir—acquired immunodeficiency syndrome	0.00223	0.00275	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.00223	0.00275	CcSEcCtD
Gonadorelin—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00222	0.00274	CcSEcCtD
Gonadorelin—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00221	0.00273	CcSEcCtD
Gonadorelin—Pain—Ritonavir—acquired immunodeficiency syndrome	0.00221	0.00272	CcSEcCtD
Gonadorelin—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.00221	0.00272	CcSEcCtD
Gonadorelin—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.00221	0.00272	CcSEcCtD
Gonadorelin—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.00218	0.00269	CcSEcCtD
Gonadorelin—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.00215	0.00265	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00214	0.00264	CcSEcCtD
Gonadorelin—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00214	0.00264	CcSEcCtD
Gonadorelin—Pain—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00262	CcSEcCtD
Gonadorelin—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.00212	0.00262	CcSEcCtD
Gonadorelin—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.00211	0.0026	CcSEcCtD
Gonadorelin—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.00211	0.0026	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.00211	0.0026	CcSEcCtD
Gonadorelin—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00209	0.00258	CcSEcCtD
Gonadorelin—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00208	0.00256	CcSEcCtD
Gonadorelin—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00206	0.00254	CcSEcCtD
Gonadorelin—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.00206	0.00253	CcSEcCtD
Gonadorelin—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.00205	0.00252	CcSEcCtD
Gonadorelin—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.00204	0.00252	CcSEcCtD
Gonadorelin—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.00204	0.00251	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.00203	0.0025	CcSEcCtD
Gonadorelin—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.00203	0.0025	CcSEcCtD
Gonadorelin—Pain—Lamivudine—acquired immunodeficiency syndrome	0.00203	0.0025	CcSEcCtD
Gonadorelin—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.002	0.00247	CcSEcCtD
Gonadorelin—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.002	0.00246	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00197	0.0105	CbGpPWpGaD
Gonadorelin—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00197	0.00243	CcSEcCtD
Gonadorelin—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.00197	0.00243	CcSEcCtD
Gonadorelin—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.00196	0.00242	CcSEcCtD
Gonadorelin—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.00196	0.00242	CcSEcCtD
Gonadorelin—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.00194	0.00239	CcSEcCtD
Gonadorelin—Headache—Indinavir—acquired immunodeficiency syndrome	0.00193	0.00238	CcSEcCtD
Gonadorelin—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00191	0.00235	CcSEcCtD
Gonadorelin—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.0019	0.00234	CcSEcCtD
Gonadorelin—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.00187	0.00231	CcSEcCtD
Gonadorelin—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.00185	0.00229	CcSEcCtD
Gonadorelin—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.00185	0.00228	CcSEcCtD
Gonadorelin—Nausea—Indinavir—acquired immunodeficiency syndrome	0.00183	0.00226	CcSEcCtD
Gonadorelin—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.00183	0.00226	CcSEcCtD
Gonadorelin—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00183	0.00225	CcSEcCtD
Gonadorelin—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00183	0.00225	CcSEcCtD
Gonadorelin—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.00178	0.0022	CcSEcCtD
Gonadorelin—GNRHR—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.00178	0.00942	CbGpPWpGaD
Gonadorelin—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00177	0.00219	CcSEcCtD
Gonadorelin—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.00177	0.00218	CcSEcCtD
Gonadorelin—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.00176	0.00217	CcSEcCtD
Gonadorelin—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00175	0.00216	CcSEcCtD
Gonadorelin—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.00175	0.00215	CcSEcCtD
Gonadorelin—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.00173	0.00214	CcSEcCtD
Gonadorelin—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.0017	0.0021	CcSEcCtD
Gonadorelin—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.0017	0.00209	CcSEcCtD
Gonadorelin—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.00168	0.00207	CcSEcCtD
Gonadorelin—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.00166	0.00204	CcSEcCtD
Gonadorelin—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.00164	0.00202	CcSEcCtD
Gonadorelin—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00162	0.002	CcSEcCtD
Gonadorelin—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00162	0.00199	CcSEcCtD
Gonadorelin—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.00158	0.00195	CcSEcCtD
Gonadorelin—GNRHR—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00157	0.00829	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.00156	0.00826	CbGpPWpGaD
Gonadorelin—Headache—Saquinavir—acquired immunodeficiency syndrome	0.00156	0.00192	CcSEcCtD
Gonadorelin—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.00153	0.00189	CcSEcCtD
Gonadorelin—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00151	0.00186	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.0015	0.00793	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.0015	0.00793	CbGpPWpGaD
Gonadorelin—Headache—Lamivudine—acquired immunodeficiency syndrome	0.00148	0.00183	CcSEcCtD
Gonadorelin—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.00148	0.00182	CcSEcCtD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00147	0.00776	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00147	0.00776	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.00142	0.0075	CbGpPWpGaD
Gonadorelin—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.00141	0.00174	CcSEcCtD
Gonadorelin—GNRHR—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00135	0.00717	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.00133	0.00705	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.00133	0.00705	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00112	0.00591	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.0011	0.00582	CbGpPWpGaD
Gonadorelin—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—acquired immunodeficiency syndrome	0.00107	0.00567	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00101	0.00536	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.00101	0.00532	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000998	0.00528	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000925	0.0049	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000913	0.00483	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000837	0.00443	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000787	0.00417	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000787	0.00417	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000599	0.00317	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.00059	0.00312	CbGpPWpGaD
Gonadorelin—GNRHR—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000581	0.00307	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000539	0.00285	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000527	0.00279	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000312	0.00165	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.00031	0.00164	CbGpPWpGaD
Gonadorelin—GNRHR—Signaling Pathways—IL6—acquired immunodeficiency syndrome	0.000183	0.00097	CbGpPWpGaD
